Understanding Attention Deficit/Hyperactivity Disorder (ADHD)
Overview of ADHD
Attention deficit/hyperactivity disorder (ADHD) ranks among the most prevalent neurodiversity conditions in children. Living with ADHD presents unique challenges not only for those diagnosed but also for their families and caregivers. The ADHD Institute estimates that approximately 2.2% of children globally are affected by this condition and will require treatment.
Diagnosing ADHD in Children
When ADHD is suspected, healthcare professionals, including psychologists, psychiatrists, and pediatricians, diagnose the condition using criteria from the latest edition of the American Psychiatric Association’s Diagnostic and Statistical Manual. To determine whether a child has ADHD and requires treatment, professionals often consult preschool teachers, school support staff, and other adults in the child’s environment to assess the following criteria.
Inattentive Behaviors
Inattentive behaviors may manifest as making careless mistakes, failing to follow instructions, not listening, quickly losing interest in tasks, and experiencing difficulties with distraction and forgetfulness.
Hyperactive and Impulsive Behaviors
Characteristics of hyperactivity and impulsivity include fidgeting, excessive talking, interrupting others, impatience while waiting, and challenges in remaining seated. These behaviors must be evident before the age of 12, and symptoms can vary significantly from child to child. For a diagnosis of ADHD, healthcare professionals typically look for at least six symptoms from both inattentive and hyperactive/impulsive categories. Additionally, it is essential to rule out other mental health and neurodiverse conditions, such as anxiety disorders and autism.
Treatment Options for ADHD
Available Treatments
It is crucial to recognize that while treatments can alleviate symptoms, they do not cure ADHD. Common treatment options include:
– Behavioral therapy
– Counseling
– Oral medication
ADHD Medications
Methylphenidate and its derivatives, such as serdexmethylphenidate and dexmethylphenidate, have been standard treatments for ADHD in patients aged six years and older for over a century. These medications are favored due to their effectiveness in reducing ADHD symptoms and their relatively low incidence of serious side effects, which may include insomnia, irritability, headache, abdominal pain, and decreased appetite.
Concerns have emerged regarding the traditional dosing methods, which typically involved administering medication two to three times a day. Ongoing research is exploring the efficacy of once-daily dosing.
Effectiveness of Once-Daily ADHD Medication
Between 2018 and 2019, researchers studied the effects of once-daily dosing of serdexmethylphenidate and dexmethylphenidate in children aged 6 to 12 diagnosed with ADHD. Participants with prior diagnoses of autism spectrum disorder, other neurodiverse conditions, mental health issues, or behavioral problems were excluded from the study. Out of 238 children who began treatment, 155 completed the study duration without any life-threatening adverse events. The results indicated a reduction in ADHD symptoms, with the most common side effects being decreased appetite (18.5%), upper respiratory infections (9.7%), pharyngeal/nasal cavity inflammation (8.0%), weight loss (7.6%), and irritability (6.7%).
Future Directions in ADHD Research
Researchers concluded that the medication is both safe and effective as a treatment for ADHD in children, suggesting that previous dosing strategies should be reevaluated. Future investigations could focus on the effectiveness of once-daily dosing with larger participant groups and over extended treatment periods. Parents interested in this medication for their child should consult their healthcare provider for personalized advice.